Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adaptimmune Therapeutics PLC

0.2653
-0.0013-0.49%
Post-market: 0.27550.0102+3.84%19:34 EDT
Volume:474.18K
Turnover:128.79K
Market Cap:68.24M
PE:-0.88
High:0.2840
Open:0.2840
Low:0.2608
Close:0.2666
Loading ...
Apr 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 24, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Major Issues Report

Form 8-K - Current report